Search - tctmd.com

Displaying 161 - 180 of 208

Sort: Relevancy | Date

News Conference News ACC 2016

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

L.A. McKeown

April 04, 2016

News Conference News ACC 2016

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

Caitlin E. Cox

April 02, 2016

News Daily News

Transcatheter Aortic Valve Outcomes Better in Women Than Men at 12 Months

Shelley Wood

February 23, 2016

News Daily News

合并左主干病变时不应排除 TAVR

L.A. McKeown

February 22, 2016

News Daily News

La Enfermedad de Tronco Coronario Izdo. Co-existente No Debería de Descartar Intervenciones TAVR

L.A. McKeown

February 22, 2016

News Daily News

Coexisting Left Main Disease Should Not Rule Out TAVR

L.A. McKeown

February 22, 2016

News Daily News

Anthracycline-Based Chemotherapy Linked to Valve Disease, Even in Absence of Radiation

L.A. McKeown

February 16, 2016

News Daily News

Cardio-Oncology Offers Fellows the Opportunity to Venture Into the ‘Wild West’

L.A. McKeown

February 15, 2016

$Successful Symetis ACURATE neo valve implantation in a elderly patient with low ejection fraction low-gradient aortic stenosis$

Presentation JIM 2016

Successful Symetis ACURATE neo valve implantation in a elderly patient with low ejection fraction low-gradient aortic stenosis

Presenter: Paolo Pagnotta

February 12, 2016

News Daily News

Expert Consensus Highlights Needs of Cancer Patients in the Cath Lab and Beyond

L.A. McKeown

January 12, 2016

News Daily News

Many Childhood Cancer Survivors Have Silent Cardiac Conditions

Yael L. Maxwell

January 06, 2016

News Daily News

低流量、低跨瓣压差患者死亡率较高，接受 AVR 可能性较低

L.A. McKeown

December 07, 2015

News Daily News

Low-Flow, Low-Gradient Patients More Likely to Die, Less Likely to Undergo AVR

L.A. McKeown

December 07, 2015

News Daily News

Los Pacientes de Flujo y Gradiente Bajos son Más Propensos a Morir y Menos a someterse a la Sustitución de la Válvula Aórtica

L.A. McKeown

December 07, 2015

Presentation

Outcome and Impact of AVR in Patients With Preserved LVEF and Low-Gradient Aortic Stenosis (AS)

Presenter: V. Dayan

December 06, 2015

News Daily News

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

September 22, 2015

News Daily News

CHOICE at 1 Year: Sapien, CoreValve Yield Similar Clinical Outcomes

August 11, 2015

News Industry News

Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet

July 23, 2015

News Industry News

Boston Scientific Announces CE Mark And FDA Clearance For Safari2 ™ Pre-Shaped Guidewire

July 22, 2015

News Daily News

EuroPCR 2015 Takes on TAVR, PCI Optimization, and More

Caitlin E. Cox

May 29, 2015

Advertisement

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

Transcatheter Aortic Valve Outcomes Better in Women Than Men at 12 Months

合并左主干病变时不应排除 TAVR

La Enfermedad de Tronco Coronario Izdo. Co-existente No Debería de Descartar Intervenciones TAVR

Coexisting Left Main Disease Should Not Rule Out TAVR

Anthracycline-Based Chemotherapy Linked to Valve Disease, Even in Absence of Radiation

Cardio-Oncology Offers Fellows the Opportunity to Venture Into the ‘Wild West’

Successful Symetis ACURATE neo valve implantation in a elderly patient with low ejection fraction low-gradient aortic stenosis

Expert Consensus Highlights Needs of Cancer Patients in the Cath Lab and Beyond

Many Childhood Cancer Survivors Have Silent Cardiac Conditions

低流量、低跨瓣压差患者死亡率较高，接受 AVR 可能性较低

Low-Flow, Low-Gradient Patients More Likely to Die, Less Likely to Undergo AVR

Los Pacientes de Flujo y Gradiente Bajos son Más Propensos a Morir y Menos a someterse a la Sustitución de la Válvula Aórtica

Outcome and Impact of AVR in Patients With Preserved LVEF and Low-Gradient Aortic Stenosis (AS)

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

CHOICE at 1 Year: Sapien, CoreValve Yield Similar Clinical Outcomes

Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet

Boston Scientific Announces CE Mark And FDA Clearance For Safari2 ™ Pre-Shaped Guidewire

EuroPCR 2015 Takes on TAVR, PCI Optimization, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content